Living with cystic fibrosis-related diabetes or type 1 diabetes mellitus: a comparative study exploring health-related quality of life and patients' reported experiences of hypoglycaemia

Abstract

Objectives: To compare patients with type 1 diabetes mellitus (T1DM) or cystic fibrosis-related diabetes (CFRD) on frequency and severity of symptoms suggestive of hypoglycaemia and diabetes-specific health-related quality of life (HRQoL).

Methods: This was a cross-sectional comparison study. Participants with T1DM or CFRD completed a questionnaire that assessed symptoms suggestive of hypoglycaemia and diabetes-specific HRQoL, and recorded episodes of low blood sugars in a prospective diary. Comparisons of responses were conducted, and Pearson product correlations were determined between HRQoL scores and other continuous variables. HRQoL scores were compared between the groups after adjusting for confounding factors.

Results: Diabetes in cystic fibrosis (CF) patients had a less negative impact on HRQoL than in T1DM patients. Both groups experienced hypoglycaemia, but loss of consciousness or needing help was more common in T1DM patients. Symptoms suggestive of hypoglycaemia were less of a problem for CFRD patients in terms of severity, with T1DM patients having more neuroglycopenic symptoms.

Discussion: Although the same percentage of patients in both groups reported experiencing hypoglycaemia, severity (e.g. symptoms and loss of consciousness) was higher for those with T1DM. Symptoms of hypoglycaemia appear to have a significant impact on HRQoL, and could account for the worse HRQoL in T1DM patients.

Keywords

Cross-sectional study Cystic fibrosis-related diabetes (CFRD)Health-related quality of life (HRQoL)Hypoglycaemia Type 1 diabetes mellitus (T1DM)

Get full access to this article

View all access options for this article.

References

Elborn JS , Shale DJ , Britton JR Cystic fibrosis: current survival and population estimates to the year 2000 . Thorax 1991; 46: 881-5.

Palermo TM , Harrison D. , Koh JL Effect of disease-related pain on the health-related quality of life of children and adolescents with cystic fibrosis. Clin J Pain 2006; 22: 532-7.

Ziaian T. , Sawyer MG , Reynolds KE , et al. Treatment burden and health-related quality of life of children with diabetes, cystic fibrosis and asthma. J Paediatr Child Health 2006; 42: 596-600.

Bowling A. Measuring disease: a review of disease-specific quality of life measurement scales, Buckingham: Open University Press, 1995.

Gee L. , Abbott J. , Hart A. , et al. Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros 2005; 4: 59-66.

Burker EJ , Carels RA , Thompson LF , et al. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung disease. Pediatr Pulmonol 2000; 30: 453-60.

Britto MT , Kotagal UR , Hornung RW , et al. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest 2002 ; 121: 64-72.

de Jong W. , Kaptein AA , van der Schans CP , et al. Quality of life in patients with cystic fibrosis. Pediatr Pulmonol 1997; 23: 95-100.

Pfeffer PE , Pfeffer JM , Hodson ME The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros 2003; 2: 61-8.

10.

Congleton J. , Hodson ME , Duncan-Skingle F. Quality of life in adults with cystic fibrosis. Thorax 1996; 51: 936-40.

11.

Brennan AL , Geddes DM , Gyi KM , Baker EH Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004; 3: 209-22.

12.

Lanng S. , Thorsteinsson B. , Nerup J. , Koch C. Influence of the development of diabetes mellitus on clinical status of patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-7.

13.

Milla C. , Warwick W. , Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-5.

14.

Bott U. , Muhlhauser I. , Overmann H. , Berger M. Validation of a diabetes-specific quality of life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-69.

15.

Department of Health. National Service Framework for Diabetes. Available at: www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002951 (accessed January 2008).

16.

Cystic Fibrosis Trust. Management of cystic fibrosis related diabetes mellitus , London: Cystic Fibrosis Trust , 2004.

17.

Azzopardi K. , Lowes L. Management of cystic fibrosis-related diabetes in adolescence. Br J Nurs 2003; 12: 359-63.

18.

Henderson JN , Allen KV , Deary IJ , Frier BM Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms and impaired awareness . Diabetic Med 2003; 20: 1016-21.

19.

Donnelly LA , Morris AD , Frier BM , et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabetic Med 2005 ; 22: 749-55.

20.

Allen C. , LeCaire T. , Palta M. , et al. Risk factors for frequent and severe hypoglycaemia in type 1 diabetes. Diabetes Care 2001; 24: 1878-81.

21.

ter Braak E. , Appelman A. , van de Laak MF , et al. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia . Diabetes Care 2000; 23: 1467-71.

22.

Deary IJ , Hepburn DA , MacLeod KM , Frier BM Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory analysis. Diabetologia 1993; 36: 771-7.

23.

Ferguson SC , Strachan MWJ , Janes JM , Frier BM Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin. Diabetes Metab Res Rev 2001; 17: 285-91.

24.

Jacobson AM , DCCT Research Group. The diabetes quality of life measure. In: Bradley C , ed. Handbook of psychology and diabetes, Amsterdam and London: Harwood Academic Publishers, 1994: 65-88.

25.

Tierney S. , Deaton C. , Webb K. , et al. `Just get on with it': patients' perspectives of living with cystic fibrosis related diabetes. Pediatr Pulm, 2007; 42(S30): 404.

26.

Battezzati A. , Battezzati PM , Costantini D. , et al. Spontaneous hypoglycemia in patients with cystic fibrosis. Eur J Endocrinol 2007 ; 156: 369-76.

27.

Pramming S. , Thorsteinsson B. , Bendtson I. , Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabetic Med 1991; 8: 817-22.

28.

Pedersen-Bjergaard U. , Pramming S. , Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-40.

29.

Clarke WL , Cox DJ , Gonder-Frederick LA , et al. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995; 18: 517-22.

30.

Corey M. , Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-89 . Am J Epidemiol 1996; 143: 1007-17.

31.

Kerem E. , Reisman J. , Corey M. , et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-91.

32.

Dcct Group. Hypoglycaemia in the diabetes control and complications trial. Diabetes 1997; 46: 271-86.

33.

Cryer PE Hypoglycemia is the limiting factor in the management of diabetes . Diabetes Metab Res Rev 1999; 15: 42-6.

34.

Polonsky WH , Davis CL , Jacobson AM , Anderson BJ Correlates of hypoglycemic fear in type 1 and type II diabetes mellitus . Health Psychol 1992; 11: 199-202.

35.

Lundkvist J. , Berne C. , Bolinder B. , Jonsson L. The economic and quality of life impact of hypoglycaemia. Eur J Health Econom 2005; 50: 197-202.

36.

Tierney S. , Deaton C. , Webb K. , et al. Isolation, motivation and balance: living with type 1 or cystic fibrosis related diabetes. J Clin Nurs (in press).

37.

DeVries JH , Snoek FJ , Heine RJ Persistent poor glycaemic control in adult type 1 diabetes: a closer look at the problem. Diabetic Med 2004; 21: 1263-8.

38.

Zhang X. , Norris SL , Chowdhury FH , et al. The effects of interventions on health related quality of life among persons with diabetes: a systematic review. Medical Care 2007; 45: 820-34.